Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	guanyl-nucleotide exchange factor activity	GAPVD1 TRIO MYCBP2 RALGPS2 PSD3 ARHGEF17 TIAM2 PLEKHG3 MCF2L DOCK6	1.87e-05	231	161	10	GO:0005085
GeneOntologyMolecularFunction	tubulin binding	OFD1 CLIP2 MAP2 APC2 TOGARAM2 AGBL5 MAP1S MTUS1 RITA1 APPL1 LRRC61 FHDC1 KIFC3	4.54e-05	428	161	13	GO:0015631
GeneOntologyMolecularFunction	low voltage-gated calcium channel activity	CACNA1H CACNA1G	1.93e-04	3	161	2	GO:0008332
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	GAPVD1 GARNL3 TRIO MYCBP2 RALGPS2 PSD3 ARHGAP39 RTKN ARHGEF17 TIAM2 PLEKHG3 MCF2L DOCK6	2.45e-04	507	161	13	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	GAPVD1 GARNL3 TRIO MYCBP2 RALGPS2 PSD3 ARHGAP39 RTKN ARHGEF17 TIAM2 PLEKHG3 MCF2L DOCK6	2.45e-04	507	161	13	GO:0030695
Domain	PH	TRIO RALGPS2 PSD3 RTKN TIAM2 CADPS PLEKHG3 APPL1 IRS2 PLEKHH2 MCF2L APBB1IP	5.90e-07	229	158	12	PF00169
Domain	PH	TRIO RALGPS2 PSD3 RTKN TIAM2 CADPS PLEKHG3 APPL1 IRS2 PLEKHH2 MCF2L APBB1IP	4.47e-06	278	158	12	SM00233
Domain	PH_DOMAIN	TRIO RALGPS2 PSD3 RTKN TIAM2 CADPS PLEKHG3 APPL1 IRS2 PLEKHH2 MCF2L APBB1IP	4.63e-06	279	158	12	PS50003
Domain	PH_domain	TRIO RALGPS2 PSD3 RTKN TIAM2 CADPS PLEKHG3 APPL1 IRS2 PLEKHH2 MCF2L APBB1IP	4.81e-06	280	158	12	IPR001849
Domain	SPOC_C	DIDO1 RBM15B SPEN	1.17e-05	6	158	3	IPR012921
Domain	SPOC	DIDO1 RBM15B SPEN	1.17e-05	6	158	3	PF07744
Domain	-	TRIO RALGPS2 PSD3 RTKN ARHGEF17 TIAM2 CADPS PLEKHG3 APPL1 IRS2 PLEKHH2 MCF2L APBB1IP	2.91e-05	391	158	13	2.30.29.30
Domain	Spectrin	TRIO SYNE1 MCF2L UTRN	3.85e-05	23	158	4	PF00435
Domain	PH_dom-like	TRIO RALGPS2 PSD3 RTKN ARHGEF17 TIAM2 CADPS PLEKHG3 APPL1 IRS2 PLEKHH2 MCF2L APBB1IP	6.99e-05	426	158	13	IPR011993
Domain	Spectrin_repeat	TRIO SYNE1 MCF2L UTRN	9.93e-05	29	158	4	IPR002017
Domain	-	MYCBP2 MARCHF9 BAZ1B DIDO1 MAP3K1 MEX3C CHFR ANKIB1 KMT2A MLLT6 BSN RNF39 KAT6B	1.18e-04	449	158	13	3.30.40.10
Domain	Znf_RING/FYVE/PHD	MYCBP2 MARCHF9 BAZ1B DIDO1 MAP3K1 MEX3C CHFR ANKIB1 KMT2A MLLT6 BSN RNF39 KAT6B	1.47e-04	459	158	13	IPR013083
Domain	SPEC	TRIO SYNE1 MCF2L UTRN	1.47e-04	32	158	4	SM00150
Domain	Spectrin/alpha-actinin	TRIO SYNE1 MCF2L UTRN	1.47e-04	32	158	4	IPR018159
Domain	DH_1	TRIO ARHGEF17 TIAM2 PLEKHG3 MCF2L	1.92e-04	63	158	5	PS00741
Domain	VDCC_T_a1	CACNA1H CACNA1G	2.12e-04	3	158	2	IPR005445
Domain	SPOC_met	RBM15B SPEN	2.12e-04	3	158	2	IPR010912
Domain	Znf_FYVE_PHD	BAZ1B DIDO1 ANKIB1 KMT2A MLLT6 BSN KAT6B	2.57e-04	147	158	7	IPR011011
Domain	RhoGEF	TRIO ARHGEF17 TIAM2 PLEKHG3 MCF2L	2.76e-04	68	158	5	SM00325
Domain	RhoGEF	TRIO ARHGEF17 TIAM2 PLEKHG3 MCF2L	3.16e-04	70	158	5	PF00621
Domain	DH_2	TRIO ARHGEF17 TIAM2 PLEKHG3 MCF2L	3.16e-04	70	158	5	PS50010
Domain	-	TRIO ARHGEF17 TIAM2 PLEKHG3 MCF2L	3.38e-04	71	158	5	1.20.900.10
Domain	DH-domain	TRIO ARHGEF17 TIAM2 PLEKHG3 MCF2L	3.38e-04	71	158	5	IPR000219
Domain	SPOC	RBM15B SPEN	4.22e-04	4	158	2	PS50917
Domain	PHD	BAZ1B DIDO1 KMT2A MLLT6 KAT6B	4.36e-04	75	158	5	PF00628
Domain	Znf_PHD-finger	BAZ1B DIDO1 KMT2A MLLT6 KAT6B	5.54e-04	79	158	5	IPR019787
Domain	-	RBM15B SPEN	6.99e-04	5	158	2	2.40.290.10
Domain	SPOC-like_C_dom	RBM15B SPEN	6.99e-04	5	158	2	IPR016194
Domain	RETICULON	RTN4 RTN2	6.99e-04	5	158	2	PS50845
Domain	PHD	BAZ1B DIDO1 KMT2A MLLT6 KAT6B	9.53e-04	89	158	5	SM00249
Domain	Znf_PHD	BAZ1B DIDO1 KMT2A MLLT6 KAT6B	1.05e-03	91	158	5	IPR001965
Domain	ZF_PHD_2	BAZ1B DIDO1 KMT2A MLLT6 KAT6B	1.28e-03	95	158	5	PS50016
Domain	ZF_PHD_1	BAZ1B DIDO1 KMT2A MLLT6 KAT6B	1.34e-03	96	158	5	PS01359
Domain	Reticulon	RTN4 RTN2	1.45e-03	7	158	2	PF02453
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	MIIP SRRM1 NCOA6 GAPVD1 SORBS2 SLC4A7 NEDD4L OFD1 TRIO MAP2 MYCBP2 INPP5E RALGPS2 PSD3 RTKN ARHGEF17 MEX3C C6orf132 FAM83H MTUS1 PLEKHG3 KMT2A GIGYF2 IRS2 RASSF8 EIF4G3 SRRM2 DOCK6 UTRN	1.35e-16	861	166	29	36931259
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	SRRM1 NCOA6 GAPVD1 SORBS2 MYCBP2 BAZ1B DIDO1 MCM4 ARHGAP39 BLM KANSL3 TRAFD1 MAP1S ZNF592 RBM15B KMT2A GIGYF2 APPL1 IRS2 KAT6B SRRM2 SPEN TP53BP1 DYNC1LI2	4.23e-13	774	166	24	15302935
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	NCOA6 OFD1 TRIO MYCBP2 INPP5E SPEG TIAM2 C6orf132 FAM83H KANSL3 ORAI1 GAREM2 MAP1S ZNF296 MEGF6 ZNF592 MLLT1 MLLT6 CACNA1H IRS2 ULK1 KIFC3 MCF2L DOCK6 SPEN PRRT4 SOWAHB	3.34e-12	1105	166	27	35748872
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	SRRM1 NEDD4L CLIP2 MAP2 MYCBP2 RTN4 PKP4 DLGAP4 ARHGAP39 HCN2 GIGYF2 BSN EIF4G3 SRRM2 DYNC1LI2	1.47e-10	347	166	15	17114649
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	NCOA6 GAPVD1 SDK2 INPP5E RTN4 DIDO1 SNRK TIAM2 KANSL3 MTUS1 ZNF592 ANKIB1 IGSF9 CACNA1G BSN KAT6B DOCK6	7.99e-10	529	166	17	14621295
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	NCOA6 CLIP2 MYCBP2 SYNE1 PSD3 SNRK MEGF6 CADPS GIGYF2 APPL1 CACNA1G KAT6B	1.02e-09	225	166	12	12168954
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SORBS2 NEDD4L SYNE1 SPEG DLGAP4 PSD3 TSC1 ARHGEF17 CADPS GIGYF2 CACNA1H ULK1 MCF2L SRRM2 SPEN	1.31e-09	407	166	15	12693553
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	SORBS2 NEDD4L TRIO CLIP2 PRR36 MYCBP2 SYNE1 PKP4 DLGAP4 APC2 DIDO1 TSC1 ARHGAP39 HCN2 GIGYF2 APPL1 ADGRA1 BSN CUX1 TP53BP1	4.03e-08	963	166	20	28671696
Pubmed	Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization.	SRRM1 GAPVD1 SLC4A7 MYCBP2 INPP5E RALGPS2 TSC1 TRA2A IRS2 RASSF8 SRRM2	4.60e-08	255	166	11	15324660
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	GAPVD1 MAP2 SPEG RTN4 TOGARAM2 TSC1 BLM TRAFD1 GRID2IP MAP1S ZNF592 KMT2A GIGYF2 IRS2	1.34e-07	497	166	14	36774506
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	SRRM1 DIDO1 MCM4 BLM TRAFD1 MAVS NUP133 TRA2A IRS2 EIF4G3 SRRM2 SPEN TP53BP1 DYNC1LI2	1.56e-07	503	166	14	16964243
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	GAPVD1 SORBS2 OFD1 PKP4 RALGPS2 RTKN MAP1S NFATC4 GIGYF2 IRS2 RASSF8 DOCK6 UTRN	2.60e-07	446	166	13	24255178
Pubmed	SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18.	RBMXL1 RNPC3 BAZ1B MAP1S RBM15B TRA2A KMT2A SPEN SPTY2D1 TP53BP1	3.97e-07	251	166	10	31076518
Pubmed	Serine 302 Phosphorylation of Mouse Insulin Receptor Substrate 1 (IRS1) Is Dispensable for Normal Insulin Signaling and Feedback Regulation by Hepatic S6 Kinase.	INSR TSC1 IRS2	4.26e-07	4	166	3	26846849
Pubmed	Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer.	SORBS2 NEDD4L MYCBP2 RALGPS2 ARHGEF17 IRS2 SRRM2	6.27e-07	102	166	7	15778465
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	SRRM1 GAPVD1 MYCBP2 BAZ1B DIDO1 MCM4 BLM NUP133 KMT2A GIGYF2 EIF4G3 SRRM2 SPEN UTRN TP53BP1	6.35e-07	653	166	15	22586326
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	NCOA6 NEDD4L APC2 MAP3K1 C6orf132 MAP1S NFATC4 MLLT6 BSN EIF4G3 NYAP1 SPEN	1.20e-06	430	166	12	35044719
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC19 MUC16 MUC5B MUC12	1.45e-06	18	166	4	18834073
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	SRRM1 SDK2 MYCBP2 DIDO1 MAP1S ZNF592 RBM15B TRA2A IRS2 SRRM2 SPEN	1.46e-06	361	166	11	26167880
Pubmed	Genomic analysis of mouse retinal development.	SPRY1 MAP2 PSD3 SUSD3 SNRK TSC1 RXRB TRAFD1 MTUS1 CADPS RP1L1 TRA2A KMT2A IGSF9 ULK1 ROBO3 BSN MCF2L	1.71e-06	1006	166	18	15226823
Pubmed	Quantitative dissection and stoichiometry determination of the human SET1/MLL histone methyltransferase complexes.	NCOA6 FOS ARHGEF17 BLM RBM15B KMT2A TP53BP1	1.78e-06	119	166	7	23508102
Pubmed	Expression of Muc19/Smgc gene products during murine sublingual gland development: cytodifferentiation and maturation of salivary mucous cells.	MUC19 MUC16 MUC5B	2.11e-06	6	166	3	19110483
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	FLG SRRM1 SORBS2 NEDD4L RBMXL1 MAP2 MYCBP2 RNPC3 SYNE1 DIDO1 ARHGAP39 BLM RBM15B TRA2A SRRM2 DOCK6 SPEN DYNC1LI2	4.69e-06	1082	166	18	38697112
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	SRRM1 GAPVD1 NEDD4L OFD1 MYCBP2 SYNE1 INSR BAZ1B MCM4 FAM83H PLEKHG3 NUP133 TRA2A GIGYF2 SRRM2 SPEN UTRN	8.99e-06	1024	166	17	24711643
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	SRRM1 NCOA6 BAZ1B DIDO1 MCM4 ARID3B BLM RBM15B KMT2A MLLT1 GIGYF2 MLLT6 SRRM2 SPEN CUX1 TP53BP1	1.48e-05	954	166	16	36373674
Pubmed	Human transcription factor protein interaction networks.	FLG NCOA6 OFD1 FOS BAZ1B DIDO1 ARID3B BLM KANSL3 ZNF592 NFATC4 KMT2A MLLT1 GIGYF2 MLLT6 RASSF8 SRRM2 SPEN CUX1 TP53BP1	1.72e-05	1429	166	20	35140242
Pubmed	Protein interactome reveals converging molecular pathways among autism disorders.	SPRY1 SORBS2 TANK MYCBP2 DLGAP4 APC2 TSC1 MEGF6 NUP133 ANKIB1 MLLT1 IGSF9	1.74e-05	560	166	12	21653829
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	SORBS2 NEDD4L TRIO CLIP2 MAP2 PRR36 SYNE1 RTN4 PKP4 DLGAP4 PSD3 TSC1 ARHGAP39 ARHGEF17 MAP1S CADPS KMT2A BSN EIF4G3 UTRN	1.76e-05	1431	166	20	37142655
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	SRRM1 NCOA6 SDK2 SYNE1 DUSP2 ARHGEF17 GIGYF2 SRRM2	1.80e-05	234	166	8	36243803
Pubmed	Cav3.2 subunit underlies the functional T-type Ca2+ channel in murine hearts during the embryonic period.	CACNA1H CACNA1G	2.26e-05	2	166	2	14988077
Pubmed	Role of T-type calcium channel subunits in post-myocardial infarction remodelling probed with genetically engineered mice.	CACNA1H CACNA1G	2.26e-05	2	166	2	21622683
Pubmed	The ENL YEATS epigenetic reader domain critically links MLL-ENL to leukemic stem cell frequency in t(11;19) Leukemia.	KMT2A MLLT1	2.26e-05	2	166	2	36435883
Pubmed	Hypertrophy in skeletal myotubes induced by junctophilin-2 mutant, Y141H, involves an increase in store-operated Ca2+ entry via Orai1.	JPH2 ORAI1	2.26e-05	2	166	2	22389502
Pubmed	Ca(v)3.2 T-type Ca2+ channel-dependent activation of ERK in paraventricular thalamus modulates acid-induced chronic muscle pain.	CACNA1H CACNA1G	2.26e-05	2	166	2	20685979
Pubmed	Hepatic mTORC1 Opposes Impaired Insulin Action to Control Mitochondrial Metabolism in Obesity.	INSR TSC1	2.26e-05	2	166	2	27346353
Pubmed	Two distinct portions of LTG19/ENL at 19p13 are involved in t(11;19) leukemia.	KMT2A MLLT1	2.26e-05	2	166	2	8378076
Pubmed	Amelioration of Muc5b mucin hypersecretion is enhanced by IL-33 after 2-APB administration in a murine model of allergic rhinitis.	MUC5B ORAI1	2.26e-05	2	166	2	24111497
Pubmed	The SRm160/300 splicing coactivator subunits.	SRRM1 SRRM2	2.26e-05	2	166	2	10668804
Pubmed	Chronic deficit in nitric oxide elicits oxidative stress and augments T-type calcium-channel contribution to vascular tone of rodent arteries and arterioles.	CACNA1H CACNA1G	2.26e-05	2	166	2	23436820
Pubmed	Deficiency of T-type Ca2+ channels Cav3.1 and Cav3.2 has no effect on angiotensin II-induced hypertension but differential effect on plasma aldosterone in mice.	CACNA1H CACNA1G	2.26e-05	2	166	2	31042060
Pubmed	Analysis of compensatory beta-cell response in mice with combined mutations of Insr and Irs2.	INSR IRS2	2.26e-05	2	166	2	17299086
Pubmed	Oocyte-Specific Expression of Mouse MEX3C652AA in the Ovary and Its Potential Role in Regulating Maternal Fos mRNA.	FOS MEX3C	2.26e-05	2	166	2	27053362
Pubmed	Long Noncoding RNA H19 Derived from M2 Tumor-Associated Macrophages Promotes Bladder Cell Autophagy via Stabilizing ULK1.	NEDD4L ULK1	2.26e-05	2	166	2	35607322
Pubmed	Association of high-level MCL-1 expression with in vitro and in vivo prednisone resistance in MLL-rearranged infant acute lymphoblastic leukemia.	MCL1 KMT2A	2.26e-05	2	166	2	19965632
Pubmed	Spliced MLL fusions: a novel mechanism to generate functional chimeric MLL-MLLT1 transcripts in t(11;19)(q23;p13.3) leukemia.	KMT2A MLLT1	2.26e-05	2	166	2	17252016
Pubmed	RNA-binding protein SORBS2 suppresses clear cell renal cell carcinoma metastasis by enhancing MTUS1 mRNA stability.	SORBS2 MTUS1	2.26e-05	2	166	2	33311452
Pubmed	Clinical outcome and monitoring of minimal residual disease in patients with acute lymphoblastic leukemia expressing the MLL/ENL fusion gene.	KMT2A MLLT1	2.26e-05	2	166	2	21953510
Pubmed	ULK1 ubiquitylation is regulated by phosphorylation on its carboxy terminus.	NEDD4L ULK1	2.26e-05	2	166	2	28820317
Pubmed	T-type voltage-activated calcium channel Cav3.1, but not Cav3.2, is involved in the inhibition of proliferation and apoptosis in MCF-7 human breast cancer cells.	CACNA1H CACNA1G	2.26e-05	2	166	2	22469755
Pubmed	Acute myeloid leukemia induced by MLL-ENL is cured by oncogene ablation despite acquisition of complex genetic abnormalities.	KMT2A MLLT1	2.26e-05	2	166	2	19029444
Pubmed	Different distribution of Cav3.2 and Cav3.1 transcripts encoding T-type Ca(2+) channels in the embryonic heart of mice.	CACNA1H CACNA1G	2.26e-05	2	166	2	21079360
Pubmed	Tyr624 and Tyr628 in insulin receptor substrate-2 mediate its association with the insulin receptor.	INSR IRS2	2.26e-05	2	166	2	9195949
Pubmed	The Ca(v)3.1 T-type calcium channel is required for neointimal formation in response to vascular injury in mice.	CACNA1H CACNA1G	2.26e-05	2	166	2	22886848
Pubmed	Delayed puberty but normal fertility in mice with selective deletion of insulin receptors from Kiss1 cells.	INSR KISS1	2.26e-05	2	166	2	23392256
Pubmed	Genetic variation in TLR or NFkappaB pathways and the risk of breast cancer: a case-control study.	TANK MAP3K1	2.26e-05	2	166	2	23634849
Pubmed	Deletion of T-type calcium channels Cav3.1 or Cav3.2 attenuates endothelial dysfunction in aging mice.	CACNA1H CACNA1G	2.26e-05	2	166	2	29082441
Pubmed	Induction of renal tumorigenesis with elevated levels of somatic loss of heterozygosity in Tsc1+/- mice on a Blm-deficient background.	TSC1 BLM	2.26e-05	2	166	2	16288003
Pubmed	[Decreased mRNA expressions of T-type channel alpha1H and alpha1G in the sperm of varicocele patients and their implication].	CACNA1H CACNA1G	2.26e-05	2	166	2	22574369
Pubmed	Structural and biochemical characterization of the KRLB region in insulin receptor substrate-2.	INSR IRS2	2.26e-05	2	166	2	18278056
Pubmed	Blockade of T-type Ca(2+) channels inhibits human ovarian cancer cell proliferation.	CACNA1H CACNA1G	2.26e-05	2	166	2	21438841
Pubmed	β-Adrenergic stimulation increases Cav3.1 activity in cardiac myocytes through protein kinase A.	CACNA1H CACNA1G	2.26e-05	2	166	2	22808078
Pubmed	AMP-activated protein kinase (AMPK) activity is not required for neuronal development but regulates axogenesis during metabolic stress.	MAP2 TSC1 CUX1	2.28e-05	12	166	3	21436046
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	SRRM1 GAPVD1 SLC4A7 INSR MUC16 APOB ARID3B BLM MAVS EIF4G3 SPEN SPTY2D1 CUX1 DYNC1LI2	2.38e-05	777	166	14	35844135
Pubmed	Phosphoproteomic analysis of the developing mouse brain.	SRRM1 MAP2 RTN4 DLGAP4 ARHGAP39 RTN2 APPL1 SRRM2	2.58e-05	246	166	8	15345747
Pubmed	Reticulons 1 and 3 are essential for axonal growth and synaptic maintenance associated with intellectual development.	MAP2 RTN4 RTN2	2.95e-05	13	166	3	37228035
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	NEDD4L TRIO MAP2 MYCBP2 INSR MACROD1 ARHGAP39 ARMC2 KANSL3 MEGF6 PLEKHG3 ANKIB1 IGSF9 CACNA1H MCF2L EIF4G3 KAT6B DOCK6 UTRN CUX1	3.08e-05	1489	166	20	28611215
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	SORBS2 SLC4A7 NEDD4L TRIO MAP2 MYCBP2 RTN4 DLGAP4 PSD3 SNRK ARHGAP39 MAP1S CADPS APPL1 BSN EIF4G3 TP53BP1	3.47e-05	1139	166	17	36417873
Pubmed	A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.	SRRM1 BTBD18 INSR MUC16 APOB IGLL5 TRAFD1 GIGYF2 SRRM2 SPEN	3.70e-05	420	166	10	28065597
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	SLC4A7 NEDD4L TRIO PKP4 DLGAP4 INSR PSD3 PPP1R37 APPL1 UTRN	3.77e-05	421	166	10	36976175
Pubmed	Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.	MIIP SRRM1 GAPVD1 SLC4A7 CLIP2 PKP4 DIDO1 RTN2 USP6 NFATC4 CHFR GIGYF2 KIFC3 MCF2L EIF4G3	4.05e-05	925	166	15	28986522
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	NCOA6 BAZ1B DIDO1 TRA2A KMT2A KAT6B SRRM2 SPEN TP53BP1	4.14e-05	341	166	9	32971831
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	SRRM1 TICRR NCOA6 FOS BAZ1B DIDO1 SQOR BLM KANSL3 NUP133 RBM15B TRA2A KMT2A MLLT1 SRRM2 SPEN SPTY2D1 CUX1	5.04e-05	1294	166	18	30804502
Pubmed	Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia.	RBMXL1 MAP2 RTN4 PKP4 BSN	5.31e-05	84	166	5	19165527
Pubmed	Tip60/KAT5 Histone Acetyltransferase Is Required for Maintenance and Neurogenesis of Embryonic Neural Stem Cells.	MAP2 CUX1 TP53BP1	5.71e-05	16	166	3	36768434
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	FAM47A TICRR GAPVD1 MUC19 ZNF831 TMEM80 ARHGEF17 MEGF6 ZNF592 TRA2A MLLT1 UTRN TMEM200C	5.72e-05	736	166	13	29676528
Pubmed	5,6-EET potently inhibits T-type calcium channels: implication in the regulation of the vascular tone.	CACNA1H CACNA1G	6.77e-05	3	166	2	24327205
Pubmed	Ethanol inhibition of a T-type Ca²+ channel through activity of protein kinase C.	CACNA1H CACNA1G	6.77e-05	3	166	2	23488970
Pubmed	DNA repair and cell cycle checkpoint defects in a mouse model of 'BRCAness' are partially rescued by 53BP1 deletion.	BLM TP53BP1	6.77e-05	3	166	2	29620483
Pubmed	Differential effect of T-type voltage-gated Ca2+ channel disruption on renal plasma flow and glomerular filtration rate in vivo.	CACNA1H CACNA1G	6.77e-05	3	166	2	24966091
Pubmed	The TSC complex is required for the benefits of dietary protein restriction on stress resistance in vivo.	INSR TSC1	6.77e-05	3	166	2	25131199
Pubmed	Tsc1 haploinsufficiency without mammalian target of rapamycin activation is sufficient for renal cyst formation in Tsc1+/- mice.	TSC1 BLM	6.77e-05	3	166	2	16912167
Pubmed	Inactivation of the nuclear receptor coactivator RAP250 in mice results in placental vascular dysfunction.	NCOA6 MAP2	6.77e-05	3	166	2	12556486
Pubmed	Glucose effects on beta-cell growth and survival require activation of insulin receptors and insulin receptor substrate 2.	INSR IRS2	6.77e-05	3	166	2	19273608
Pubmed	Identification of the t-type calcium channel (Ca(v)3.1d) in developing mouse heart.	CACNA1H CACNA1G	6.77e-05	3	166	2	11230107
Pubmed	PRIP promotes tumor formation through enhancing serum-responsive factor-mediated FOS expression.	NCOA6 FOS	6.77e-05	3	166	2	19329434
Pubmed	Homeostatic plasticity and burst activity are mediated by hyperpolarization-activated cation currents and T-type calcium channels in neuronal cultures.	CACNA1H CACNA1G	6.77e-05	3	166	2	33547341
Pubmed	Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice.	KMT2A MLLT1	6.77e-05	3	166	2	10995463
Pubmed	Calmodulin regulates Cav3 T-type channels at their gating brake.	CACNA1H CACNA1G	6.77e-05	3	166	2	28972185
Pubmed	Simultaneous localization of MLL, AF4 and ENL genes in interphase nuclei by 3D-FISH: MLL translocation revisited.	KMT2A MLLT1	6.77e-05	3	166	2	16433901
Pubmed	Differential Expression of MUC12, MUC16, and MUC20 in Patients with Active and Remission Ulcerative Colitis.	MUC16 MUC12	6.77e-05	3	166	2	26770020
Pubmed	ZnT-1 enhances the activity and surface expression of T-type calcium channels through activation of Ras-ERK signaling.	CACNA1H CACNA1G	6.77e-05	3	166	2	22572848
Pubmed	Association of insulin receptor H1085H C>T, insulin receptor substrate 1 G972R and insulin receptor substrate 2 1057G/A polymorphisms with refractory temporal lobe epilepsy in Han Chinese.	INSR IRS2	6.77e-05	3	166	2	25458098
Pubmed	Genetic deficiency of glycogen synthase kinase-3beta corrects diabetes in mouse models of insulin resistance.	INSR IRS2	6.77e-05	3	166	2	18288891
Pubmed	T-type, but not L-type, voltage-gated calcium channels are dispensable for lymphatic pacemaking and spontaneous contractions.	CACNA1H CACNA1G	6.77e-05	3	166	2	31919478
Pubmed	Alpha(1H) mRNA in single skeletal muscle fibres accounts for T-type calcium current transient expression during fetal development in mice.	CACNA1H CACNA1G	6.77e-05	3	166	2	11897840
Pubmed	Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2.	INSR IRS2	6.77e-05	3	166	2	10642598
Pubmed	BLM helicase-dependent and -independent roles of 53BP1 during replication stress-mediated homologous recombination.	BLM TP53BP1	6.77e-05	3	166	2	17591918
Pubmed	Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias.	KMT2A MLLT1	6.77e-05	3	166	2	1423624
Pubmed	Construction of a Mex3c Gene-Deficient Mouse Model to Study C-FOS Expression in Hypothalamic Nuclei and Observe Morphological Differences in Embryonic Neural Tube Development.	FOS MEX3C	6.77e-05	3	166	2	33191393
Pubmed	A conserved arginine-containing motif crucial for the assembly and enzymatic activity of the mixed lineage leukemia protein-1 core complex.	KMT2A MLLT1	6.77e-05	3	166	2	18829457
Interaction	YWHAH interactions	MIIP SRRM1 TICRR NCOA6 GAPVD1 SORBS2 SLC4A7 NEDD4L OFD1 TRIO MAP2 MYCBP2 INPP5E SPEG RALGPS2 PSD3 TSC1 RTKN ARHGEF17 ZFP36 MEX3C C6orf132 FAM83H GRID2IP MTUS1 PLEKHG3 RBM15B KMT2A GIGYF2 APPL1 IRS2 RASSF8 EIF4G3 SRRM2 DOCK6 UTRN	5.52e-13	1102	164	36	int:YWHAH
Interaction	YWHAG interactions	MIIP SRRM1 TICRR NCOA6 GAPVD1 SORBS2 SLC4A7 NEDD4L MAP2 MYCBP2 INPP5E SPEG RALGPS2 PSD3 TSC1 RTKN ARHGEF17 ZFP36 MAP3K1 C6orf132 FAM83H GRID2IP MTUS1 PLEKHG3 RBM15B TRA2A KMT2A GIGYF2 APPL1 IRS2 ULK1 RASSF8 EIF4G3 SRRM2 UTRN	8.77e-11	1248	164	35	int:YWHAG
Interaction	YWHAB interactions	MIIP TICRR GAPVD1 SORBS2 SLC4A7 NEDD4L MAP2 MYCBP2 INPP5E SPEG INSR RALGPS2 PSD3 TSC1 RTKN ARHGEF17 ZFP36 C6orf132 FAM83H GRID2IP PLEKHG3 KMT2A GIGYF2 APPL1 IRS2 RASSF8 SRRM2	5.07e-08	1014	164	27	int:YWHAB
Interaction	YWHAZ interactions	MIIP TICRR GAPVD1 SORBS2 SLC4A7 NEDD4L CLIP2 MAP2 MYCBP2 INPP5E SPEG RALGPS2 PSD3 TSC1 RTKN SQOR MAP3K1 C6orf132 FAM83H ARID3B MTUS1 NFATC4 PLEKHG3 KMT2A GIGYF2 APPL1 IRS2 ULK1 RASSF8 TP53BP1 IL9R	7.73e-08	1319	164	31	int:YWHAZ
Interaction	TOP3B interactions	NCOA6 OFD1 TRIO MYCBP2 INPP5E SPEG APOB ZFP36 TIAM2 C6orf132 FAM83H KANSL3 ORAI1 GAREM2 MAP1S ZNF296 MEGF6 ZNF592 MLLT1 MLLT6 CACNA1H IRS2 ULK1 KIFC3 MCF2L DOCK6 SPEN PRRT4 SOWAHB TP53BP1	2.52e-06	1470	164	30	int:TOP3B
Interaction	SFN interactions	MIIP NCOA6 GAPVD1 SORBS2 SLC4A7 NEDD4L MAP2 MYCBP2 INSR RALGPS2 ARHGEF17 ZFP36 C6orf132 FAM83H MTUS1 PLEKHG3 KMT2A IRS2 SRRM2	3.77e-06	692	164	19	int:SFN
Interaction	MAPRE1 interactions	SORBS2 OFD1 TRIO CLIP2 MAP2 TPRN APC2 BAZ1B FAM83H MAP1S MAVS MTUS1 NUP133 GIGYF2 SRRM2 DYNC1LI2	4.86e-06	514	164	16	int:MAPRE1
Interaction	YWHAQ interactions	MIIP TICRR NCOA6 SORBS2 SLC4A7 NEDD4L MAP2 MYCBP2 SPEG RALGPS2 PSD3 TSC1 RTKN ZFP36 MAP3K1 C6orf132 FAM83H MTUS1 NFATC4 PLEKHG3 KMT2A APPL1 IRS2 RASSF8	1.28e-05	1118	164	24	int:YWHAQ
Interaction	YWHAE interactions	MIIP TICRR GAPVD1 SORBS2 SLC4A7 NEDD4L MYCBP2 INPP5E RALGPS2 PSD3 TSC1 RTKN MAP3K1 MEX3C C6orf132 FAM83H ARID3B PLEKHG3 KMT2A GIGYF2 APPL1 IRS2 ULK1 RASSF8 SRRM2	2.96e-05	1256	164	25	int:YWHAE
Interaction	FBXO22 interactions	GAPVD1 MAP2 SPEG RTN4 TOGARAM2 TSC1 BLM TRAFD1 GRID2IP MAP1S ZNF592 KMT2A GIGYF2 IRS2 TP53BP1	3.67e-05	540	164	15	int:FBXO22
Interaction	ASF1A interactions	NCOA6 FOS MCM4 BLM ZNF592 KMT2A MLLT6 SPEN SPTY2D1 CUX1	3.84e-05	249	164	10	int:ASF1A
Interaction	OCLN interactions	SDK2 SLC4A7 NEDD4L SYT12 TRIO PKP4 DLGAP4 INSR PSD3 KLRG2 ARHGAP39 ULK1 RASSF8 UTRN	6.17e-05	500	164	14	int:OCLN
Cytoband	Ensembl 112 genes in cytogenetic band chr19p13	PRR36 APC2 INSR MUC16 HCN2 S1PR5 MAP1S ZNF556 MLLT1 DOCK6 MADCAM1	1.76e-04	797	167	11	chr19p13
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	RALGPS2 PSD3 RTKN TIAM2 CADPS PLEKHG3 APPL1 IRS2 PLEKHH2 MCF2L APBB1IP	5.63e-08	206	111	11	682
GeneFamily	CD molecules\|Mucins	MUC19 MUC16 MUC5B MUC12	7.43e-06	21	111	4	648
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	TRIO ARHGEF17 TIAM2 PLEKHG3 MCF2L	5.28e-05	66	111	5	722
GeneFamily	PHD finger proteins	BAZ1B DIDO1 KMT2A MLLT6 KAT6B	2.31e-04	90	111	5	88
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	SDK2 TRIO SPEG HEPACAM2 IGSF9 ROBO3	4.76e-04	161	111	6	593
GeneFamily	RNA binding motif containing	RBMXL1 RNPC3 ZCRB1 RBM15B TRA2A SPEN	2.02e-03	213	111	6	725
GeneFamily	Immunoglobulin lambda locus at 22q11.2	IGLV3-27 IGLV3-25 IGLV3-16 IGLV3-10	2.20e-03	89	111	4	353
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	PKP4 APC2 ARMC2	2.32e-03	43	111	3	409
Coexpression	GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_UP	MCL1 TSC1 IRAG1 MAP3K1 USP6 MEGF6 BIN2 FAM8A1 APBB1IP	5.09e-06	198	166	9	M5344
Coexpression	GROSS_HYPOXIA_VIA_ELK3_DN	NEDD4L FOS DUSP2 ZFP36 MAP3K1 TIAM2 CD93 CACNA1H	6.83e-06	155	166	8	M1304
Coexpression	GROSS_HYPOXIA_VIA_ELK3_DN	NEDD4L FOS DUSP2 ZFP36 MAP3K1 TIAM2 CD93 CACNA1H	8.62e-06	160	166	8	MM1126
Coexpression	HE_LIM_SUN_FETAL_LUNG_C0_MYL4_POS_SMC_CELL	ALKAL1 SPEG RALGPS2 JPH2 IRAG1 SSC5D FHDC1	1.46e-05	124	166	7	M45673
Coexpression	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	NCOA6 SLC4A7 TANK CLIP2 INPP5E FOS DLGAP4 INSR TSC1 RTN2 ZFP36 ARID3B MAP1S MTUS1 IRS2 ULK1 CUX1	1.97e-05	822	166	17	M6782
Coexpression	UNTERMAN_IPF_VS_CTRL_CD4T_DN	FOS DUSP2 ZFP36	2.90e-05	10	166	3	M48280
Coexpression	GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_UP	FOS MEGF6 ZNF592 BIN2 IRS2 SPTY2D1 FAM8A1 CUX1	3.22e-05	192	166	8	M4174
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	GAPVD1 SLC4A7 TANK TRIO MYCBP2 PKP4 PSD3 BAZ1B BLM USP6 NUP133 GIGYF2 EIF4G3 KAT6B SPEN CUX1 TP53BP1	3.29e-05	856	166	17	M4500
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	GAPVD1 SLC4A7 TRIO MYCBP2 PKP4 BLM USP6 GIGYF2 EIF4G3 KAT6B SPEN CUX1	4.46e-05	466	166	12	M13522
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#1	GARNL3 MAP2 PRR36 APC2 PSD3 RTN2 SSC5D CACNA1H MCF2L SPEN TP53BP1	2.15e-05	306	160	11	Facebase_RNAseq_e10.5_Maxillary Arch_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#3	SPRY1 SORBS2 GARNL3 MAP2 PRR36 APC2 INSR PSD3 RTKN RTN2 CACNA1H	5.47e-05	339	160	11	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K3
CoexpressionAtlas	kidney single cell_adult_JuxtaGlomCell_Ren1Gfp_StemCellamp_top-relative-expression-ranked_1000	TRIO AVPR1B FOS INSR JPH2 ARMC2 ZFP36 S1PR5 SSC5D MEGF6 IRS2 PLEKHH2 RNF39 HSF4 DOCK6	5.87e-05	608	160	15	gudmap_kidney single cell_adult_JuxtaGlomCell_Ren1Gfp_Scamp_1000
ToppCell	ILEUM-inflamed-(6)_ILC\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	SPRY1 SPN FOS DUSP2 MCL1 ZFP36 MEX3C S1PR5 RASSF8	5.32e-08	194	167	9	4d51d49366c34ff1241770b4acc0167a43b3155a
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	SPN SYNE1 DUSP2 ZNF831 S1PR5 KMT2A MLLT6 SRRM2 UTRN	6.07e-08	197	167	9	836061acd7f0d5de89b16f52ec679bdf09eac9db
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 FOS DUSP2 BAZ1B ZFP36 KMT2A EIF4G3 UTRN	4.89e-07	184	167	8	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	3'-Adult-LargeIntestine-Mesenchymal-Pericytes-Pericyte\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MAP2 TOGARAM2 IRAG1 ARHGEF17 RTN2 ZFP36 NFATC4 PLEKHH2	5.52e-07	187	167	8	150023e6a50c9da461f2321074d2d5e96caafb06
ToppCell	facs-Heart-RA-3m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP2 IRAG1 HCN2 ARHGEF17 GAREM2 MEGF6 PLEKHG3 IGSF9	6.23e-07	190	167	8	bfbdf16d488359d7935a419c4c1823288f39c183
ToppCell	facs-Heart-RA-3m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP2 IRAG1 HCN2 ARHGEF17 GAREM2 MEGF6 PLEKHG3 IGSF9	6.23e-07	190	167	8	eb1f8bb4d903b08e50c2dc173b06c0c79d8e316e
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SPRY1 SPN FOS DUSP2 ZFP36 S1PR5 BIN2 RASSF8	6.74e-07	192	167	8	df4741e7684f010445f0224a1fd61aaa4fae02b3
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-innate_lymphocytic\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SPRY1 SPN FOS DUSP2 ZFP36 S1PR5 BIN2 RASSF8	7.58e-07	195	167	8	63e132fd6e4318299dd47bbe8ed3bf120efe46dd
ToppCell	Tracheal-10x3prime_v2-Immune_Lymphocytic-T-T_CD8-CD8_TRM\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	SPN DUSP2 SUSD3 BLM PROB1 BIN2 APBB1IP IL9R	7.58e-07	195	167	8	c75d04b15d9f95fe2b5650cd4a5a376776610000
ToppCell	10x3'2.3-week_17-19\|World / cell types per 3 fetal stages;per 3',per 5'	FOS MCL1 ZFP36 MEX3C ZNF296 TRA2A IRS2 SRRM2	8.18e-07	197	167	8	f5cfad0b42d0f817e22cc78b9bfb2b4b7e4330ed
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SPN SYNE1 DUSP2 ZFP36 MEX3C S1PR5 PLEKHG3 BIN2	8.50e-07	198	167	8	2fdb92b198ba24e326e90479fd024400d956fb32
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-innate_lymphocytic\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SPN SYNE1 DUSP2 ZFP36 MEX3C S1PR5 PLEKHG3 BIN2	8.50e-07	198	167	8	326e97bdc27cc3440f5488c2519446580cdc9d51
ToppCell	Tracheal\|World / Cell types per location group and 10X technology with lineage, and cell group designations	SORBS2 GARNL3 PKP4 INSR PSD3 MUC16 MUC5B MCF2L	9.17e-07	200	167	8	682960e28542a3d6c119047cd0131941932cfdea
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	TRIO PKP4 SNRK CD93 KMT2A MCF2L DOCK6 UTRN	9.17e-07	200	167	8	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	356C-Lymphocytic-ILC-ILC-3\|356C / Donor, Lineage, Cell class and subclass (all cells)	SPRY1 LDLRAD2 MCL1 SNRK HCN2 PROB1 KAT6B	1.92e-06	154	167	7	923f5eb8e9258105dbdbe57a5e7976ef60dae29b
ToppCell	facs-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SPN DUSP2 ARHGAP39 TIAM2 S1PR5 PLEKHG3 APBB1IP	2.28e-06	158	167	7	121d63b8e2e37107467b170e5b2c798a7dbf6325
ToppCell	facs-Trachea-nan-18m-Myeloid-lymphocyte_of_B_lineage\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RALGPS2 HEPACAM2 ZNF831 ZNF296 INSL6 CACNA1H BFSP2	2.48e-06	160	167	7	5c9281706009558c8361bfa76169f43ffc0f7947
ToppCell	facs-Trachea-18m-Hematologic-lymphocytic-B_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RALGPS2 HEPACAM2 ZNF831 ZNF296 INSL6 CACNA1H BFSP2	2.92e-06	164	167	7	4274a4f225cabf61f0fe27d8ea162b4eba612f87
ToppCell	facs-Trachea-18m-Hematologic-lymphocytic-B_cell-B_cell_of_the_trachea\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RALGPS2 HEPACAM2 ZNF831 ZNF296 INSL6 CACNA1H BFSP2	2.92e-06	164	167	7	d62143450f59097ad4b34603a6257f897a769ead
ToppCell	PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SPN FOS SUSD3 MCL1 S1PR5 BIN2 APBB1IP	3.56e-06	169	167	7	70c841a7b1e3f665105d715a6d72762c80ce5de2
ToppCell	PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SPN FOS SUSD3 MCL1 S1PR5 BIN2 APBB1IP	3.56e-06	169	167	7	1077fbca61bd0c1f9706aeb0552b77362127f261
ToppCell	droplet-Lung-1m-Hematologic-myeloid-non-classical_monocyte\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SPN DUSP2 SUSD3 ZFP36 TIAM2 S1PR5 APBB1IP	3.85e-06	171	167	7	00739085fdbc4d64c9faacba2c2adeab580dd2b1
ToppCell	droplet-Lung-1m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SPN DUSP2 SUSD3 ZFP36 TIAM2 S1PR5 APBB1IP	4.00e-06	172	167	7	5f58ff6cac32546d07b2a49ed250b6c7aa417188
ToppCell	droplet-Marrow-nan-3m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZMYND15 FOS SYNE1 ZFP36 S1PR5 SERAC1 EIF4G3	4.48e-06	175	167	7	cf53a15bfb37b6019e7052ffdf594a9ac040900e
ToppCell	5'-Adult-Appendix-Hematopoietic-T_cells-CX3CR1+_CD8_Tmem\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SPN SYNE1 DUSP2 S1PR5 BIN2 UTRN APBB1IP	4.65e-06	176	167	7	6b06da40eb97ea2db09f3a769494738b3e5fe3fa
ToppCell	facs-GAT-Fat-24m-Lymphocytic-B_cell\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RALGPS2 SLC39A4 HEPACAM2 ZNF296 INSL6 CACNA1H BFSP2	4.83e-06	177	167	7	f4afe10522eed77318954210224496f09d372532
ToppCell	facs-SCAT-Fat-24m-Lymphocytic-B_cell\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RALGPS2 SUSD3 SLC39A4 HEPACAM2 MAP3K1 ZNF296 INSL6	5.59e-06	181	167	7	14faef1dde781d501834379f2a6413e8d6a80b72
ToppCell	droplet-Spleen-nan-18m\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SRRM1 MYCBP2 FOS DUSP2 RALGPS2 ZFP36 SRRM2	5.80e-06	182	167	7	eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c
ToppCell	ILEUM-inflamed-(1)_T_cell-(1)_CD8_Trm\|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	SPRY1 SLC4A7 OFD1 FOS MCL1 ZFP36 TRA2A	6.23e-06	184	167	7	cef3ee2a4a0af961aa3b4c92150d423e841ae8c1
ToppCell	5'-GW_trimst-2-LymphNode-Hematopoietic-B_cells-Pre-B\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGLL5 IGLV3-25 IGLV3-16 IGLV3-10 ZNF296 BFSP2 APBB1IP	6.45e-06	185	167	7	0fa7970709dc957dea95fabbd83263a0335babd5
ToppCell	droplet-Heart-4Chambers-21m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SORBS2 SPEG JPH2 IRAG1 PLEKHG3 CACNA1H CACNA1G	6.45e-06	185	167	7	30df02fbe2828e3c4f3e5c4cda855e74fb31be39
ToppCell	COVID-19-kidney-FLT1+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SPRY1 SLC4A7 INSR SNRK CD93 MCF2L DOCK6	6.45e-06	185	167	7	673308ca0514a4d3629d61fe91e9d8fb31b72166
ToppCell	droplet-Heart-4Chambers-21m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SORBS2 SPEG JPH2 IRAG1 PLEKHG3 CACNA1H CACNA1G	6.92e-06	187	167	7	8ff9f771d10c372d771c92dfa9006aa81aec4681
ToppCell	COVID-19-Epithelial-Ionocytes\|COVID-19 / Condition, Lineage and Cell class	SORBS2 ALKAL1 PRR36 MUC16 HEPACAM2 CACNA1H ADGRA1	7.17e-06	188	167	7	a581cb9528d0febbf3addbb4f6bc140f91a584e6
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51\|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)	SRRM1 FOS SYNE1 DUSP2 MLLT6 SRRM2 UTRN	7.42e-06	189	167	7	0e8d1be3c406d1a393e18faccfe89116a8f82bcf
ToppCell	renal_medulla_nuclei-Adult_normal_reference\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	SLC4A7 FOS ZFP36 MTUS1 RASSF8 EIF4G3 UTRN	7.68e-06	190	167	7	f1363f7806cfc4f14fbc1b0e8dac2de813a88eee
ToppCell	COVID-19-kidney-VWF+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SPRY1 PKP4 INSR SNRK CD93 MCF2L DOCK6	7.95e-06	191	167	7	2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982
ToppCell	T_cells-CD56_dim_CD16+_NK_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	SPN SYNE1 MEX3C S1PR5 PLEKHG3 BIN2 EIF4G3	8.80e-06	194	167	7	335c6c2f3f319d4f19eace62f8826a0f40c130f6
ToppCell	droplet-Fat-Mat-18m-Endothelial-Cd36+\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SORBS2 PKP4 SNRK CD93 MEGF6 MCF2L UTRN	8.80e-06	194	167	7	74d0eaa76f6d9af14110dfe5b4bf9751b99ff6e3
ToppCell	ILEUM-inflamed-(6)_ILC1\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	OFD1 FOS DUSP2 ZFP36 MEX3C S1PR5 IRS2	8.80e-06	194	167	7	dc9ca407ec3ebec1a3dea1213a2beef28c1dc043
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SPRY1 SPN FOS DUSP2 ZFP36 RASSF8 KAT6B	9.09e-06	195	167	7	d70b49f6b9c6c4422adb2936c837a1af7569fb0a
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	SPN SYNE1 ZNF831 S1PR5 PLEKHG3 MLLT6 UTRN	9.40e-06	196	167	7	418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SPN SYNE1 ZNF831 S1PR5 PLEKHG3 MLLT6 UTRN	9.40e-06	196	167	7	581fc8c8d42005aacd7b401a2c9d1fc331fb4af7
ToppCell	droplet-Mammary_Gland-nan-3m-Epithelial-luminal_epithelial_cell_of_mammary_gland\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPRN RTKN ARHGEF17 C6orf132 FAM83H PLEKHG3 SOWAHB	9.40e-06	196	167	7	9554ac6eb5f381bcde3ba40c32aa3fc340974540
ToppCell	droplet-Mammary_Gland-nan-3m-Epithelial-luminal_progenitor_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP2 TPRN RTKN C6orf132 FAM83H PLEKHG3 SOWAHB	9.40e-06	196	167	7	22fcfb713f402ebbd43b2822f0fd919cdbfba6e4
ToppCell	CV-Moderate-6\|CV / Virus stimulation, Condition and Cluster	MIIP ORAI1 TRA2A KMT2A APPL1 SRRM2 SPTY2D1	9.40e-06	196	167	7	7bced0cc2112697593c478fa291b8ed3941fb811
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	SPN SYNE1 ZNF831 S1PR5 PLEKHG3 MLLT6 UTRN	9.40e-06	196	167	7	6beaf0c2799424c59819b286fbb5c1a83d85e4d1
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SPN SYNE1 ZNF831 S1PR5 PLEKHG3 MLLT6 UTRN	9.40e-06	196	167	7	c35f2349dfe35baa845f790b9f31673dceac54c0
ToppCell	lymphoid-T_cell-Regulatory_T_cell\|lymphoid / Lineage, cell class and subclass	FOS DUSP2 ZFP36 PLEKHG3 IGSF9 BIN2 KISS1	9.72e-06	197	167	7	73d5dcf076caae60ea32258b4e9dcac8979a661e
ToppCell	COVID_vent-Lymphocytic-T_cell-CD8+_Memory_T_cell\|COVID_vent / Disease condition, Lineage, Cell class and subclass	SPN SYNE1 DUSP2 S1PR5 PLEKHG3 MLLT6 UTRN	9.72e-06	197	167	7	d4dfb3b561d0783cdbee4e8d27009ad81df695cb
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SPN SYNE1 DUSP2 ZNF831 S1PR5 MLLT6 UTRN	1.00e-05	198	167	7	a1b310274aa9b3d2aa1fe9488d67422bf4ac81d2
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	SPN SYNE1 DUSP2 ZNF831 S1PR5 MLLT6 UTRN	1.00e-05	198	167	7	a781fd35a7cda8b7760c2e3ddccaac7aac26c979
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	SPN SYNE1 DUSP2 ZNF831 S1PR5 MLLT6 UTRN	1.00e-05	198	167	7	df399674345c45738d765a8354ea8d1484572c34
ToppCell	Control-Control-Lymphocyte-T/NK-NK_activated\|Control / Disease, condition lineage and cell class	SPN SYNE1 MEX3C S1PR5 MLLT6 EIF4G3 UTRN	1.00e-05	198	167	7	76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7
ToppCell	healthy_donor-Lymphocytic-ILC-NK_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	SPN SYNE1 S1PR5 PLEKHG3 MLLT6 BIN2 UTRN	1.00e-05	198	167	7	d7053a898e04478c577381085f615edaad3cdc5b
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SPN SYNE1 DUSP2 MEX3C S1PR5 MLLT6 BIN2	1.00e-05	198	167	7	c54da37aa11f82a68e591d563b3db9121d6b498f
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_cytokine_secreting_effector_T_cell\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	OFD1 SYNE1 DUSP2 MEX3C S1PR5 KAT6B UTRN	1.00e-05	198	167	7	34c564ece9a2b94dcf646e3c95b5be9c5ecfaafe
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-innate_lymphocytic\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SPN SYNE1 DUSP2 MEX3C S1PR5 MLLT6 BIN2	1.00e-05	198	167	7	90023468f3498548a92d75928f476b4157bde813
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SPN SYNE1 DUSP2 ZNF831 S1PR5 MLLT6 UTRN	1.00e-05	198	167	7	76aff381403bc5a8a9cc73eb1e5dbdc0bac7de6c
ToppCell	healthy_donor-Lymphocytic-ILC\|healthy_donor / Disease condition, Lineage, Cell class and subclass	SPN SYNE1 S1PR5 PLEKHG3 MLLT6 BIN2 UTRN	1.00e-05	198	167	7	aa33be29e26f1b8facfc894413099083ae3bbb1b
ToppCell	356C-Fibroblasts-Fibroblast-J_(Lipofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	FOS DUSP2 SUSD3 MCL1 ZFP36 LRRC61 TMEM200C	1.04e-05	199	167	7	f4fdf94c561dca35bb17766d908c5030655f43eb
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SPN SYNE1 S1PR5 PLEKHG3 MLLT6 BIN2 UTRN	1.04e-05	199	167	7	4820f5bcd7bc34c2ebf6a3422cc8eb383a3b5a4e
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-naive_thymus-derived_CD8-positive,_alpha-beta_T_cell\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SLC4A7 SPN SYNE1 ZNF831 S1PR5 ORAI1 BIN2	1.04e-05	199	167	7	db05c16d80f5a74bfa048a5c92917d312d26f769
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SPN SYNE1 S1PR5 PLEKHG3 MLLT6 BIN2 UTRN	1.04e-05	199	167	7	eb05ccae5187e4701bbbe6d714a6d2808fbcf306
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	SPN SYNE1 S1PR5 PLEKHG3 MLLT6 BIN2 UTRN	1.04e-05	199	167	7	10c8729b779073c3bf808e85958d59147f0be5c5
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SPN SYNE1 S1PR5 PLEKHG3 MLLT6 BIN2 UTRN	1.04e-05	199	167	7	867fd292f3879982422e840e087bfdb3b21a8715
ToppCell	Control-Lymphoid_T/NK-NK\|Control / Disease group, lineage and cell class	SPN SYNE1 S1PR5 PLEKHG3 MLLT6 BIN2 UTRN	1.04e-05	199	167	7	94b2693a8378b9b2c58c6aebb2c6658d75b2e3de
ToppCell	356C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	FOS DUSP2 SUSD3 MCL1 ZFP36 LRRC61 TMEM200C	1.04e-05	199	167	7	c0fe99ed906d0eb99cccdab9a1fa32c17b3542e7
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-gd_T\|COVID-19_Mild / Disease, condition lineage and cell class	SPN SYNE1 DUSP2 ZNF831 S1PR5 MLLT6 UTRN	1.07e-05	200	167	7	6560753d3df2f87860b52052d4881aa45410f666
ToppCell	Control-Control-Lymphocyte-T/NK-NK\|Control / Disease, condition lineage and cell class	SPN SYNE1 S1PR5 PLEKHG3 MLLT6 BIN2 UTRN	1.07e-05	200	167	7	c64c27dbf4df42ca2ad2bd94b50fab87b4050ef3
ToppCell	mild-gd_T\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SYNE1 DUSP2 S1PR5 KMT2A MLLT6 SRRM2 UTRN	1.07e-05	200	167	7	109f673a4967ffa52270a0b4f818b3461288db44
ToppCell	mild-NK\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SPN SYNE1 MEX3C S1PR5 PLEKHG3 MLLT6 UTRN	1.07e-05	200	167	7	a11fb1d7e124c352eb73fea0e0ec0fed577c97f7
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated\|COVID-19_Mild / Disease, condition lineage and cell class	SPN SYNE1 S1PR5 PLEKHG3 MLLT6 EIF4G3 UTRN	1.07e-05	200	167	7	2281debd86e5d92e8fe0397aec9ef670800f7471
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SLC4A7 ALKAL1 SYNE1 IRAG1 SSC5D MTUS1 RASSF8	1.07e-05	200	167	7	dcdaec3ca3a3024dc1b8788c417003f84c2bffdc
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T\|COVID-19_Severe / Disease, condition lineage and cell class	SPN SYNE1 ZNF831 S1PR5 PLEKHG3 MLLT6 UTRN	1.07e-05	200	167	7	f72bc3f6606ae77fe1b0a972e35b3ce0727804d9
ToppCell	Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2\|Hippocampus / BrainAtlas - Mouse McCarroll V32	SPN AVPR1B PSD3 ZNF831 CACNA1H ROBO3	1.96e-05	147	167	6	8f725ff8fb4ced5db2643e80669d3f7945b820ab
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal--glomerular_mesenchymal_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SPEG DUSP2 IRAG1 CADPS BFSP2 KISS1	2.55e-05	154	167	6	3211f003f4d1735c7cab9b6cc68af3e0bbfba35e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SPEG DUSP2 IRAG1 CADPS BFSP2 KISS1	2.55e-05	154	167	6	4c2a7590791c2255b15dab82c3622f71f9ffd949
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SPEG DUSP2 IRAG1 CADPS BFSP2 KISS1	2.55e-05	154	167	6	c0fe767fc9ab45b2dfa71171f2a673a4a8decbaf
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-Z\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SPN SYNE1 ORAI1 ZNF556 MLLT6 BIN2	3.05e-05	159	167	6	bf8ff9251bcb64b2b9d6dd93461aec97659686ec
ToppCell	facs-Lung-18m-Hematologic-myeloid-non-classical_monocyte\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SPN DUSP2 ARHGAP39 TIAM2 S1PR5 APBB1IP	3.16e-05	160	167	6	bc4a93dc5f37829799c37877e751ff3bc122e4ab
ToppCell	droplet-Lung-18m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l44\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SPN DUSP2 BAZ1B S1PR5 INSL6 CACNA1H	3.16e-05	160	167	6	6b0faaa371650563f585722f5b2fb319e124ec38
ToppCell	Adult-Immune-mast_cell\|Adult / Lineage, Cell type, age group and donor	SRRM5 LDLRAD2 HCN2 GAREM2 CADPS IL9R	3.27e-05	161	167	6	44f5c0256b3ce264a6c7b62740f32dcd45ee052d
ToppCell	Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SPEG JPH2 IRAG1 ARHGEF17 SSC5D CACNA1H	3.51e-05	163	167	6	8f24cef152f5965727bbeee116bd26c75cbba82a
ToppCell	facs-Heart-RA-24m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RALGPS2 SUSD3 SLC39A4 HEPACAM2 ZNF296 IL9R	3.75e-05	165	167	6	36415924d05373e9dd3665be599f4f3f40bf0497
ToppCell	facs-Heart-RA-24m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RALGPS2 SUSD3 SLC39A4 HEPACAM2 ZNF296 IL9R	3.75e-05	165	167	6	56310fddd3d8e4afdfde066d26cee9747e5b8c6a
ToppCell	10x5'-blood-Lymphocytic_NK-NK_CD56bright_CD16-\|blood / Manually curated celltypes from each tissue	SPRY1 LDLRAD2 DUSP2 TOGARAM2 ZNF296 RASSF8	3.88e-05	166	167	6	ba42349a68b22e91a0340bda1ccecd6c7592392f
ToppCell	facs-Heart-LV-24m-Lymphocytic\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPN RALGPS2 SUSD3 SLC39A4 HEPACAM2 INSL6	4.02e-05	167	167	6	4a669eafde3582a451614ad304769b47aa1d9578
ToppCell	3'-Adult-LargeIntestine-Epithelial-goblet-Goblet_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NEDD4L FOS HEPACAM2 ZNF296 CADPS SOWAHB	4.15e-05	168	167	6	2163e6774eb7a3d010422e4d59be5e45b4158329
ToppCell	droplet-Liver-Npc-18m-Lymphocytic-B_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPN TOGARAM2 HEPACAM2 ZNF296 CACNA1H BFSP2	4.15e-05	168	167	6	ce9fae8b295c668b0959d5007a8bcd401d80e258
ToppCell	droplet-Lung-30m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SPN DUSP2 ZFP36 TIAM2 S1PR5 APBB1IP	4.15e-05	168	167	6	d823979335ac6b5d1f062ebb741c759d2f919dbf
ToppCell	droplet-Lung-30m-Hematologic-myeloid-non-classical_monocyte\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SPN DUSP2 ZFP36 TIAM2 S1PR5 APBB1IP	4.15e-05	168	167	6	f377ff4c066a9857ad14d245e56325ad220e22e1
ToppCell	facs-Heart-LV-24m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPN RALGPS2 SUSD3 SLC39A4 HEPACAM2 INSL6	4.29e-05	169	167	6	ae85cef7ef8f761c19f4af2a23fe333641c38a92
ToppCell	facs-Heart-LV-24m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPN RALGPS2 SUSD3 SLC39A4 HEPACAM2 INSL6	4.29e-05	169	167	6	c01bc3f2f299109086ded83dc11e98559bf1940c
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_D3\|367C / Donor, Lineage, Cell class and subclass (all cells)	FOS DUSP2 MCL1 ZFP36 ZNF296 BIN2	4.43e-05	170	167	6	7a8b90ff37c5b3b31820924a3e7f4ce20319f896
ToppCell	facs-Lung-nan-3m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DUSP2 RALGPS2 MAP3K1 BLM ZNF296 BFSP2	4.58e-05	171	167	6	a31c23406cf6d6a17358a8fb41d392a7fb0306e0
ToppCell	droplet-Liver-Npc-18m-Lymphocytic-B_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPN TOGARAM2 HEPACAM2 ZNF296 CACNA1H BFSP2	4.58e-05	171	167	6	584a095ddcbf78aa29527f84b46b5ad3e2edbaa9
ToppCell	facs-Lung-nan-3m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DUSP2 RALGPS2 MAP3K1 BLM ZNF296 BFSP2	4.58e-05	171	167	6	43d8fd9b9546e84a652564fe96b514b34b06262b
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SORBS2 DUSP2 FAM83H ORAI1 MLLT1 IRS2	4.58e-05	171	167	6	7b0783d25055e5ea5b2fc44ebcb16bfd0adbcf81
ToppCell	droplet-Lung-nan-21m-Myeloid-non-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPN ZFP36 TIAM2 S1PR5 GUCY2F APBB1IP	4.73e-05	172	167	6	51bea97564a33f0060c546c9be4bf8bf8f1660f6
Drug	Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Down 200; 5.8uM; PC3; HT_HG-U133A	MIIP TANK SPN PSD3 TMEM80 MTUS1 TRA2A RASSF8 UTRN	1.19e-05	195	163	9	4508_DN
Drug	AC1MNCFH	SYNE1 INSR CUX1	1.23e-05	7	163	3	CID003301780
Drug	PNU-0230031 [267429-39-0]; Up 200; 10uM; PC3; HT_HG-U133A	SORBS2 MAP2 PRR36 PKP4 ARHGEF17 MAP3K1 MEGF6 PLEKHG3 RASSF8	1.23e-05	196	163	9	4288_UP
Drug	Betonicine [515-25-3]; Down 200; 25.2uM; MCF7; HT_HG-U133A	NDUFAF5 TRIO SYNE1 DUSP2 ARHGEF17 ZNF592 CACNA1H RASSF8 ROBO3	1.29e-05	197	163	9	4767_DN
Drug	Edrophonium chloride [116-38-1]; Up 200; 19.8uM; MCF7; HT_HG-U133A	SPRY1 NEDD4L SPN DUSP2 DLGAP4 ARHGEF17 MAP3K1 CACNA1H IRS2	1.34e-05	198	163	9	1519_UP
Drug	Captopril [62571-86-2]; Up 200; 17.2uM; MCF7; HT_HG-U133A	SPRY1 SPEG MUC5B TMEM80 ARHGEF17 MAP3K1 IRS2 MCF2L MADCAM1	1.39e-05	199	163	9	1488_UP
Drug	Lanatoside C [17575-22-3]; Up 200; 4uM; PC3; HT_HG-U133A	SLC4A7 NEDD4L FOS MCL1 ZFP36 TRA2A KMT2A IRS2	1.97e-05	159	163	8	4328_UP
Disease	sexual dimorphism measurement	NCOA6 GAPVD1 INPP5E MARCHF9 RTN4 DLGAP4 INSR BAZ1B MCL1 APOB ARMC2 SSC5D ZNF592 NFATC4 TRA2A BSN TP53BP1	9.64e-05	1106	158	17	EFO_0021796
Disease	hereditary spastic paraplegia 12 (implicated_via_orthology)	RTN4 RTN2	1.70e-04	4	158	2	DOID:0110765 (implicated_via_orthology)
Disease	triglyceride measurement, alcohol consumption measurement	INSR MACROD1 PSD3 APOB TP53BP1	2.16e-04	101	158	5	EFO_0004530, EFO_0007878
Disease	Malignant neoplasm of breast	NCOA6 TANK FOS SYNE1 APC2 SUSD3 HEPACAM2 RXRB MAP3K1 GUCY2F NUP133 APPL1 KAT6B SPEN CUX1 TP53BP1	2.22e-04	1074	158	16	C0006142
Disease	alkaline phosphatase measurement	LDLRAD2 NEDD4L INPP5E PSD3 BAZ1B SLC39A4 APOB TRAFD1 NFATC4 RP1L1 PPP1R37 PLEKHH2 EIF4G3 UTRN TP53BP1	3.81e-04	1015	158	15	EFO_0004533
Disease	cholangiocarcinoma (is_marker_for)	MUC16 MUC5B RASSF8 RNF39	3.92e-04	64	158	4	DOID:4947 (is_marker_for)
Disease	brain disease (implicated_via_orthology)	MYCBP2 TIAM2	4.21e-04	6	158	2	DOID:936 (implicated_via_orthology)
Disease	bipolar disorder (is_implicated_in)	AVPR1B SYNE1 KAT6B	4.97e-04	29	158	3	DOID:3312 (is_implicated_in)
Disease	Ovarian Mucinous Adenocarcinoma	SPEG SNRK ULK1	6.06e-04	31	158	3	C1335167
Disease	free cholesterol to total lipids in large LDL percentage	MACROD1 PSD3 APOB TP53BP1	6.80e-04	74	158	4	EFO_0022280
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Positive	MAP2 FOS DUSP2 MEX3C KAT6B	7.15e-04	131	158	5	C4704862
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Negative	MAP2 FOS DUSP2 MEX3C KAT6B	7.15e-04	131	158	5	C4552091
Disease	Juvenile arthritis	MAP2 FOS DUSP2 MEX3C KAT6B	7.15e-04	131	158	5	C3495559
Disease	Juvenile psoriatic arthritis	MAP2 FOS DUSP2 MEX3C KAT6B	7.15e-04	131	158	5	C3714758
Disease	Juvenile-Onset Still Disease	MAP2 FOS DUSP2 MEX3C KAT6B	8.19e-04	135	158	5	C0087031
Disease	triglyceride measurement, very low density lipoprotein cholesterol measurement	INSR PSD3 APOB ARMC2 SQOR TP53BP1	1.35e-03	224	158	6	EFO_0004530, EFO_0008317
Disease	free cholesterol to total lipids in very small VLDL percentage	PSD3 APOB TP53BP1	1.59e-03	43	158	3	EFO_0022290
Disease	age at assessment, pelvic organ prolapse	SORBS2 PSD3 JPH2	1.59e-03	43	158	3	EFO_0004710, EFO_0008007
Disease	saturated fatty acids measurement	PSD3 APOB TP53BP1	1.81e-03	45	158	3	EFO_0022304
Disease	coronary artery disease	NCOA6 SORBS2 LDLRAD2 PSD3 MCL1 APOB IRAG1 ZNF831 MAP3K1 MAP1S GIGYF2 PLEKHH2 BSN MCF2L DOCK6	1.95e-03	1194	158	15	EFO_0001645
Disease	triglyceride measurement, alcohol drinking	INSR MACROD1 PSD3 TP53BP1	2.01e-03	99	158	4	EFO_0004329, EFO_0004530
Disease	Diuretic use measurement	TICRR INSR JPH2 ZNF831 MEX3C	2.21e-03	169	158	5	EFO_0009928
Disease	Agents acting on the renin-angiotensin system use measurement	TICRR INSR MACROD1 JPH2 ZNF831 MEX3C NFATC4	2.26e-03	335	158	7	EFO_0009931
Disease	platelet component distribution width	SRRM1 GAPVD1 SLC4A7 TANK SYNE1 ZNF831 MAVS PLEKHG3 IRS2 NYAP1 CUX1	2.58e-03	755	158	11	EFO_0007984
Disease	polyunsaturated fatty acids to monounsaturated fatty acids ratio	PSD3 APOB TP53BP1	2.60e-03	51	158	3	EFO_0022302
Disease	Williams-Beuren syndrome (implicated_via_orthology)	CLIP2 BAZ1B	2.86e-03	15	158	2	DOID:1928 (implicated_via_orthology)
Disease	Autosomal Recessive Centronuclear Myopathy	SPEG ORAI1	2.86e-03	15	158	2	C3645536
Disease	Antihypertensive use measurement	SRRM1 NEDD4L PKP4 INSR ZNF831 CACNA1H	3.13e-03	265	158	6	EFO_0009927
Disease	triglycerides in very large HDL measurement	PSD3 APOB TP53BP1	3.22e-03	55	158	3	EFO_0022324
Disease	Dermatitis	FLG ZFP36	3.25e-03	16	158	2	C0011603
Disease	methylcobalamin deficiency type cblE, brain serotonin transporter measurement	TRIO PSD3	3.25e-03	16	158	2	EFO_0004569, MONDO_0009354
Disease	cardiovascular disease	SRRM1 INSR MACROD1 JPH2 APOB ZNF831 MEX3C MCF2L	3.33e-03	457	158	8	EFO_0000319
Disease	triglycerides in LDL measurement	PSD3 APOB TP53BP1	3.39e-03	56	158	3	EFO_0022320
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	TRIO SRRM2	3.68e-03	17	158	2	DOID:0060307 (is_implicated_in)
Disease	triglyceride measurement, high density lipoprotein cholesterol measurement	ZMYND15 PSD3 APOB RP1L1 DOCK6 TP53BP1	3.68e-03	274	158	6	EFO_0004530, EFO_0004612
Disease	triglycerides in IDL measurement	PSD3 APOB TP53BP1	3.75e-03	58	158	3	EFO_0022149
Disease	serum gamma-glutamyl transferase measurement	SORBS2 NEDD4L SYT12 MACROD1 PSD3 BAZ1B MCL1 MAP1S RP1L1 KMT2A ULK1 TP53BP1	3.87e-03	914	158	12	EFO_0004532
Disease	triglycerides to total lipids in small LDL percentage	PSD3 APOB TP53BP1	3.93e-03	59	158	3	EFO_0022337
Disease	cholesterol in chylomicrons and extremely large VLDL measurement	PSD3 APOB TP53BP1	4.12e-03	60	158	3	EFO_0021898
Disease	glucose measurement	MYCBP2 RTN4 PSD3 ARMC2 PLEKHH2 BSN APBB1IP	4.51e-03	380	158	7	EFO_0004468
Disease	triglycerides in medium LDL measurement	PSD3 APOB TP53BP1	4.52e-03	62	158	3	EFO_0022322
Disease	triglycerides to total lipids in very large HDL percentage	MACROD1 APOB TP53BP1	4.52e-03	62	158	3	EFO_0022339
Disease	free cholesterol to total lipids in medium LDL percentage	PSD3 APOB TP53BP1	4.73e-03	63	158	3	EFO_0022283
Disease	phospholipids in chylomicrons and extremely large VLDL measurement	PSD3 APOB TP53BP1	4.73e-03	63	158	3	EFO_0022292
Disease	IGF-1 measurement	TICRR SORBS2 NEDD4L BAZ1B AGBL5 GAREM2 INSL6 DOCK6	4.93e-03	488	158	8	EFO_0004627
Disease	systolic blood pressure, alcohol drinking	SLC4A7 INSR ZNF831 RP1L1	5.05e-03	128	158	4	EFO_0004329, EFO_0006335
Disease	Familial aplasia of the vermis	OFD1 INPP5E	5.08e-03	20	158	2	cv:C0431399
Disease	triglycerides in small LDL measurement	PSD3 APOB TP53BP1	5.16e-03	65	158	3	EFO_0022323

Protein segments in the cluster

Peptide	Gene	Start	Entry
ISTGVSPSRGSLRTS	PKP4	226	Q99569
PRGISRPSSGLTAAS	nan	91	Q6ZRM9
GPTSPTPRTRESSEL	AGBL5	806	Q8NDL9
TLLSATAGRPSGSTP	ARID3B	51	Q8IVW6
TTTSSSGRARAPSPG	MLLT6	411	P55198
SPSARSGRAAPSSEG	CUX1	1321	P39880
TRAPRNSGGTPRTSS	BAZ1B	451	Q9UIG0
TPSGSRSAEIFPRDS	ALKAL1	56	Q6UXT8
SSDSRPISGTRLSPL	ARMC2	81	Q8NEN0
PVRRSSDTSGSPATP	APBB1IP	521	Q7Z5R6
PSSLDGSPRSSRTDS	ADGRA1	441	Q86SQ6
GSTVPRAATASPTRG	CD93	491	Q9NPY3
STLDIPEGGSSSRRP	ANKIB1	796	Q9P2G1
GGRPSRSGLLTETSS	CLIP2	331	Q9UDT6
SGPRTSRPRGSSVSQ	FLG	2231	P20930
TSPRASLGTGTASPR	BIN2	446	Q9UBW5
SFRGPRSSSSLESPP	BFSP2	26	Q13515
SLDSSTRPPSVTRGG	DLGAP4	611	Q9Y2H0
STLPTRSALPGTTGS	MUC5B	1691	Q9HC84
RARPTGTASTASKEP	MUC5B	1726	Q9HC84
GPSLSERPTSDSVAR	RASSF8	81	Q8NHQ8
PSGRGSSSSAKRPRE	RBM15B	11	Q8NDT2
PRASAESSPGRGSSV	ARHGAP39	116	Q9C0H5
RGGTSSRRLSSTPLP	OFD1	726	O75665
SSRLAVTDPTRPGAT	KAT6B	396	Q8WYB5
ERPSGIPERFSGSSS	IGLV3-16	71	A0A075B6K0
PGSRRPSADSESPGT	ARHGEF17	136	Q96PE2
SAPSGARLSPSRTSE	CADPS	26	Q9ULU8
ARLSPSRTSEGSAGS	CADPS	31	Q9ULU8
RLPRGSSGSSSTRPG	FHDC1	956	Q9C0D6
SSGSSSTRPGRDVPL	FHDC1	961	Q9C0D6
TYGTPSSRVEGTPRS	MCM4	91	P33991
ERPSGIPERFSGSSS	IGLV3-25	71	P01717
SRTEALSLGRTSTPG	MUC16	8741	Q8WXI7
LSLGRTSTPGPAQST	MUC16	8746	Q8WXI7
RAISGSGSPFSRTES	MUC16	10296	Q8WXI7
SQPGRTSSSPILDTR	MUC16	10386	Q8WXI7
PVGRRSSLSSRGTPT	NUP133	51	Q8WUM0
SRSVTPSEGAGRRSP	JPH2	521	Q9BR39
SRSLTPSPALGSAGS	LDLRAD2	231	Q5SZI1
QGSTHTPRSPGSTRT	MADCAM1	276	Q13477
PKTATRGPSGSASSR	MAP1S	921	Q66K74
RASRLPGPTGSVVST	MAVS	236	Q7Z434
PKSRGVLSSERGSPS	INPP5E	141	Q9NRR6
KRPSGIPERFSGSSS	IGLV3-10	71	A0A075B6K4
ASSRPSGSETARSVP	FOS	276	P01100
PDGEGSSRRPTLTTF	SPN	331	P16150
TAGSLPPTGRRSGST	MTUS1	186	Q9ULD2
SPALRRTGSTPSIAS	MTUS1	791	Q9ULD2
SSLRPSSSPGPRATE	LRRC61	181	Q9BV99
GQSRPPTARTSSSGS	APPL1	416	Q9UKG1
VSSRPSTPGLSVVSG	GAPVD1	756	Q14C86
QRSGRSPSVSPDRGS	BSN	136	Q9UPA5
TPTRASESPARGPSG	DYNC1LI2	376	O43237
SPTRSLPRSASSFEG	CCDC120	286	Q96HB5
LPPSGGSTTSGSRRS	ORAI1	16	Q96D31
LPPTGDKTSRSDSRA	DUSP2	151	Q05923
RKSRSSPGDSPSAVS	IRAG1	171	Q9Y6F6
GTTGPSSRESVTTRP	MUC19	2141	Q7Z5P9
SAGVTGTRPSSSRES	MUC19	2701	Q7Z5P9
GTRPSSSRESATTGP	MUC19	2706	Q7Z5P9
TSSTGRIRATGSEAP	MUC19	6356	Q7Z5P9
RRGTSLSPPPESSGS	KISS1	66	Q15726
TSSGTGAEDPRPSRK	INSR	746	P06213
TSESDSRSRSGPGSP	PLEKHH2	636	Q8IVE3
NSRTGPTSGATSRPP	MARCHF9	286	Q86YJ5
TPTEQRISVSSPGRG	PPP1R37	551	O75864
RSSPGSSRKTTPSPG	NCOA6	1331	Q14686
PGSSGNRRSPVSSSK	NCOA6	1801	Q14686
GTPGTSSDSRQRSPL	IRS2	961	Q9Y4H2
SILSGSSSVPATPGR	BTBD18	281	B2RXH4
ARGEGSPSEATRLPT	C6orf132	731	Q5T0Z8
SSGVPGTADSRSATR	APOB	61	P04114
SSLSSLSSAGRPGPS	APC2	1071	O95996
SSTEPSPAGRERSSS	CHFR	191	Q96EP1
DPGASVGSSRSSLRS	IGLL5	51	B9A064
DAKPSSRSSDGSRGP	GRID2IP	766	A4D2P6
AGGSSTPSPRPSTRF	KLRG2	136	A4D1S0
SPGISLSSSRGPGRS	BLM	1296	P54132
DSRRGSGSPEDTPRS	DOCK6	171	Q96HP0
GSRASISQGPPTASR	DOCK6	1226	Q96HP0
RALSSGGSITSPPLS	GIGYF2	16	Q6Y7W6
ALGPASRRTSSSGSA	CACNA1G	1061	O43497
GRSPRLSFSSGSLTP	GUCY2F	541	P51841
VTVSGRDPRTAPSSS	DIDO1	961	Q9BTC0
LAGATRTRSSTCGPP	MACROD1	31	Q9BQ69
SPEGTRLSPSSDGRR	HSF4	271	Q9ULV5
PSPGIRRGSENSSSE	MCF2L	581	O15068
VPASSLSVRLGPSGS	MCF2L	1106	O15068
RGSSLRSEPSETGVS	FAM47A	346	Q5JRC9
RLVATSPGSSLPGAT	KANSL3	731	Q9P2N6
SSSASSGPALLRVGP	KMT2A	96	Q03164
SGVSRIPSRSVPASD	HEPACAM2	421	A8MVW5
KGSRSAPGTSPRTSS	MLLT1	306	Q03111
SPTPGFSTRRGSPTT	FAM83H	881	Q6ZRV2
AAPSLPDSRRGSSSS	CACNA1H	1096	O95180
VGRTRESVPSSGPTN	SDK2	1191	Q58EX2
LPARPGTAGTTSTRA	S1PR5	226	Q9H228
ASSSTPRLGPTPAAR	HCN2	841	Q9UL51
GSTPSTPVEFDSRRT	EIF4G3	1111	O43432
TSSLPRSPGRSTEDL	MENT	151	Q9BUN1
KPGAVRSSSSDRIPS	GARNL3	946	Q5VVW2
VGSAAPSRSPSETGR	FAM8A1	221	Q9UBU6
AGASPPSTLTPDSRR	MCL1	61	Q07820
TIAPTGGSPRSQDSR	nan	141	A6NNC1
PGTSTPRSAASREDL	RALGPS2	286	Q86X27
ASGGLTEDSSTRRPP	NYAP1	101	Q6ZVC0
SPSGRTVKSESPGVR	MAP3K1	256	Q13233
PASSRPTSRSGGPAR	MEGF6	1526	O75095
LSSGPRTTSGPVATS	GAREM2	646	Q75VX8
TSRRPSDSGPPAERS	RTKN	101	Q9BST9
STPAAPKRRGSSGSV	RTN4	171	Q9NQC3
SGTPQAGTPSPSRSR	RTN2	211	O75298
ASTRGPPSRKGSLSI	SYT12	86	Q8IV01
QPLTSPESRTARGGS	UTRN	1401	P46939
LSSSGRPTASVIPSG	SQOR	96	Q9Y6N5
PGIPRALSLSGSSSS	SUSD3	206	Q96L08
CRRIGTSTSPPKSGT	SERAC1	11	Q96JX3
LPSSRAGTPAGSRCT	SLC4A7	286	Q9Y6M7
SPKRSAPSGLVRSSS	RBMXL1	161	Q96E39
SATRPSPSPERSSTG	SRRM2	346	Q9UQ35
QTSPKGGRSRSSSPV	SRRM2	1091	Q9UQ35
GGRSRSSSPVTELAS	SRRM2	1096	Q9UQ35
RALPSLNTGSSSPRG	TRAFD1	316	O14545
TSAPETRRGRAPSSG	TMEM80	31	Q96HE8
SGSVSPTSGRSTPNR	SYNE1	8681	Q8NF91
RLEGSPPTRRDSGSS	TMEM200C	511	A6NKL6
SGTLSVPTRLSGPCR	TOGARAM2	406	Q6ZUX3
ERPSGIPERFSGSSS	IGLV3-27	71	P01718
TPSSASPALSRRGSL	NFATC4	276	Q14934
AVSQRTTSPGGRPSA	PLEKHG3	1021	A1L390
TTSPGGRPSARSPLS	PLEKHG3	1026	A1L390
ASPARGRGTNPVSTS	INSL6	86	Q9Y581
APSSGTSSRPGSIRR	KIFC3	806	Q9BVG8
RAGPTRSAGTSSRNP	PRR36	76	Q9H6K5
ATPLSSPARSGPSAR	PRR36	246	Q9H6K5
NGGSTSSSPPESRRK	MEX3C	591	Q5U5Q3
SLGTSSLRDPEPSGR	MIIP	116	Q5JXC2
RGASSRDPVPLISSS	SLC39A4	246	Q6P5W5
SSPRKETSARSLGSP	TANK	116	Q92844
SSSRAESPGPGSRLS	MYCBP2	2806	O75592
TSLTRPAPPDSEGSR	IL9R	416	Q01113
GSSSPAIRRLPDTGS	SSC5D	916	A1L4H1
SGVSPRGSTSPRTLN	NDUFAF5	31	Q5TEU4
TSPLGGARSSSQRSP	PROB1	776	E7EW31
DSNPSRRTVSGTCGP	SPTY2D1	421	Q68D10
PTNTSGTTRRCAGPS	SNRK	616	Q9NRH2
GLSVSRKEGSPSRSP	SOWAHB	441	A6NEL2
RTSPGRVDLPGSSTT	SORBS2	276	O94875
SVSISVPSTPRRGGA	RITA1	246	Q96K30
SGRDSRSPDSSSPNP	RXRB	76	P28702
DVTTSERTRSPPGSS	C12orf60	166	Q5U649
SPSTLAATTRGLPSR	AVPR1B	251	P47901
GETKTPRPSSARGSS	TSC1	1016	Q92574
PFLSSARRSVSGSPE	TICRR	826	Q7Z2Z1
SSSSLSPPRGDRTLL	RNPC3	16	Q96LT9
SETSPVPEARRGSSA	TIAM2	206	Q8IVF5
QASRPTRSPSGSGSR	SPEN	261	Q96T58
ATSGSSAPGESRSRL	SPEG	2531	Q15772
SSPRKESGRSQSGSP	SRRM5	381	B3KS81
RPGSQTGPSSSRASS	RP1L1	2291	Q8IWN7
RVSSSRSVSGSPEPA	SRRM1	746	Q8IYB3
PSSSGGCLVTPSRRE	ROBO3	1126	Q96MS0
GRESRSQSKSPTGTP	TRA2A	11	Q13595
PTGTPARVKSESRSG	TRA2A	21	Q13595
ADTSSSRPGSRVPTE	ZNF592	931	Q92610
GSVGKSSARPRPSTD	ZNF556	346	Q9HAH1
PSRASLTGSPSRASL	nan	331	Q9UF83
LTGSPSRASLTGTPS	nan	336	Q9UF83
TGTPSRASLIGTPSR	nan	346	Q9UF83
GTPSRASLIGTPSRA	nan	356	Q9UF83
SLTGTPPRASLTGTS	nan	371	Q9UF83
SPSGVTSRLPGRSTS	ZFP36	46	P26651
SLLPESTSRRSGPSD	PRRT4	126	C9JH25
STSRRSGPSDGPTAP	PRRT4	131	C9JH25
ARGPILSRSTSTGSA	SPRY1	106	O43609
SRTTGTRETAVPGPL	TP53BP1	1406	Q12888
SGRGSASFLRPPSTA	IGSF9	1026	Q9P2J2
PIRRAGKSGTSTPTT	MAP2	1581	P11137
SSVRPESSRLPEGSS	TPRN	641	Q4KMQ1
KPSSGVPSTSDDSRR	ZCRB1	186	Q8TBF4
GSSGTVPTQDRRTPV	ZNF831	666	Q5JPB2
GRDSPCSGSRSPLVS	ZNF831	736	Q5JPB2
GPRASVSRASSSSGP	TMEM70	31	Q9BUB7
PGAPRARSTLDSATS	TMEM271	191	A0A286YF58
VSVRPGSGISARPSS	ZMYND15	566	Q9H091
RPGTSSGTFSPVRLD	PSD3	371	Q9NYI0
SPSPSGRAGPFSSSR	ULK1	411	O75385
SSPNSSPRTLGRSKG	USP6	1191	P35125
RRLSPQTGTPGTTAV	nan	126	Q8N7P7
SCGGAPSTSRSRPSR	TRIO	2326	O75962
SRTRSSSGTGLSSPP	TMEM39B	41	Q9GZU3
SSRGGPPSARSKAVT	RNF39	41	Q9H2S5
ASGSGLTRRSPTCPV	ZNF296	221	Q8WUU4
RGESTTSRISPGSTE	MUC12	2296	Q9UKN1
PSAPAGRARSSTVTG	NEDD4L	356	Q96PU5